Molecular basis and current insights of atypical Rho small GTPase in cancer
- PMID: 38236467
- DOI: 10.1007/s11033-023-09140-7
Molecular basis and current insights of atypical Rho small GTPase in cancer
Abstract
Atypical Rho GTPases are a subtype of the Rho GTPase family that are involved in diverse cellular processes. The typical Rho GTPases, led by RhoA, Rac1 and Cdc42, have been well studied, while relative studies on atypical Rho GTPases are relatively still limited and have great exploration potential. With the increase in studies, current evidence suggests that atypical Rho GTPases regulate multiple biological processes and play important roles in the occurrence and development of human cancers. Therefore, this review mainly discusses the molecular basis of atypical Rho GTPases and their roles in cancer. We summarize the sequence characteristics, subcellular localization and biological functions of each atypical Rho GTPase. Moreover, we review the recent advances and potential mechanisms of atypical Rho GTPases in the development of multiple cancers. A comprehensive understanding and extensive exploration of the biological functions of atypical Rho GTPases and their molecular mechanisms in tumors will provide important insights into the pathophysiology of tumors and the development of cancer therapeutic strategies.
Keywords: Atypical Rho GTPases; Cancer; Cytoskeleton; Small GTPase.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Rho GTPases: Regulation and roles in cancer cell biology.Small GTPases. 2016 Oct;7(4):207-221. doi: 10.1080/21541248.2016.1232583. Epub 2016 Sep 14. Small GTPases. 2016. PMID: 27628050 Free PMC article. Review.
-
Rho GTPases in cancer: friend or foe?Oncogene. 2019 Dec;38(50):7447-7456. doi: 10.1038/s41388-019-0963-7. Epub 2019 Aug 19. Oncogene. 2019. PMID: 31427738 Review.
-
Biochemical analyses of the Wrch atypical Rho family GTPases.Methods Enzymol. 2006;406:11-26. doi: 10.1016/S0076-6879(06)06002-2. Methods Enzymol. 2006. PMID: 16472646 Review.
-
Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling.Adv Exp Med Biol. 2022;1357:115-127. doi: 10.1007/978-3-030-88071-2_5. Adv Exp Med Biol. 2022. PMID: 35583642
-
Activated Rho GTPases in Cancer-The Beginning of a New Paradigm.Int J Mol Sci. 2018 Dec 8;19(12):3949. doi: 10.3390/ijms19123949. Int J Mol Sci. 2018. PMID: 30544828 Free PMC article. Review.
Cited by
-
Cutaneous squamous cell carcinoma-derived exosomal MicroRNA-31 acts as an oncogene by targeting the tumor suppressor RhoBTB1.Arch Dermatol Res. 2024 Dec 14;317(1):114. doi: 10.1007/s00403-024-03558-0. Arch Dermatol Res. 2024. PMID: 39673615
-
Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages.Cell Death Dis. 2025 Apr 11;16(1):278. doi: 10.1038/s41419-025-07573-5. Cell Death Dis. 2025. PMID: 40216763 Free PMC article.
References
-
- Vetter IR, Wittinghofer A (2001) The guanine nucleotide-binding switch in three dimensions. Science, New York, N.Y. 294(5545):1299-1304
-
- Freymann DM, Keenan RJ, Stroud RM, Walter P (1999) Functional changes in the structure of the SRP GTPase on binding GDP and Mg2 + GDP. Nat Struct Biol 6(8):793–801 - PubMed
-
- Donovan S, Shannon KM, Bollag G (2002) GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta 1602(1):23–45 - PubMed
-
- Seabra MC (1998) Membrane association and targeting of prenylated ras-like GTPases. Cell Signal 10(3):167–172 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous